Stay updated on Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.

Latest updates to the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays the completed CONFIRM Phase III mesothelioma trial record, including its nivolumab-versus-placebo design, participant criteria, outcome measures, and UK study locations.SummaryDifference65%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page otherwise remains a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedA notice about NIH’s terminology transition appears above the unavailable study record, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study details, with a minimal header/footer shown; the previously available study content and links appear to have been removed, indicating restricted access to the record.SummaryDifference19%

Stay in the know with updates to Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Blockade in Relapsed Mesothelioma Clinical Trial page.